Skip to Content

SEC Filings

Filing date	Form	Description	View
Mar 05, 2012	POS AM	Post-effective amendment to an S-Type filing	0001047469-12-002107.pdf 0001047469-12-002107.rtf 0001047469-12-002107.xls View HTML
Mar 23, 2012	POS AM	Post-effective amendment to an S-Type filing	0001047469-12-003206.pdf 0001047469-12-003206.rtf 0001047469-12-003206.xls View HTML
Jun 16, 2017	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-17-206058.pdf 0001193125-17-206058.rtf 0001193125-17-206058.xls View HTML
Apr 13, 2018	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001564590-18-008151.pdf 0001564590-18-008151.rtf 0001564590-18-008151.xls View HTML
Apr 10, 2020	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-20-103890.pdf 0001193125-20-103890.rtf 0001193125-20-103890.xls View HTML
Apr 07, 2023	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-23-094728.pdf 0001193125-23-094728.rtf 0001193125-23-094728.xls View HTML
Mar 05, 2024	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-24-059357.pdf 0001193125-24-059357.rtf 0001193125-24-059357.xls View HTML
Aug 05, 2019	PREC14A	Preliminary proxy statement containing contested solicitations	0001193125-19-213083.pdf 0001193125-19-213083.rtf 0001193125-19-213083.xls View HTML
Aug 06, 2019	PREC14A	Preliminary proxy statement containing contested solicitations	0000921895-19-002103.pdf 0000921895-19-002103.rtf 0000921895-19-002103.xls View HTML
Jan 24, 2017	PREM14A	A preliminary proxy statement relating to a merger or acquisition	0001193125-17-016852.pdf 0001193125-17-016852.rtf 0001193125-17-016852.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2024 Merrimack Pharmaceuticals.